Cargando…
At-Risk Phenotype of Neurofibromatose-1 Patients: A Multicentre Case-Control Study
OBJECTIVES: To assess associations between subcutaneous neurofibromas (SC-NFs) and internal neurofibromas in patients with neurofibromatosis type 1 (NF-1) and to determine whether the association between SC-NFs and peripheral neuropathy was ascribable to internal neurofibromas. PATIENTS AND METHODS:...
Autores principales: | Sbidian, Emilie, Bastuji-Garin, Sylvie, Valeyrie-Allanore, Laurence, Ferkal, Salah, Lefaucheur, Jean P, Drouet, Alain, Brugière, Pierre, Vialette, Cédric, Combemale, Patrick, Barbarot, Sébastien, Wolkenstein, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149567/ https://www.ncbi.nlm.nih.gov/pubmed/21752287 http://dx.doi.org/10.1186/1750-1172-6-51 |
Ejemplares similares
-
Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional study
por: Sbidian, Emilie, et al.
Publicado: (2012) -
Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France
por: Duong, Tu Anh, et al.
Publicado: (2011) -
Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966
por: Bergqvist, Christina, et al.
Publicado: (2020) -
Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review
por: Zehou, Ouidad, et al.
Publicado: (2013) -
Metabolic Tumour Burden Measured by (18)F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1
por: Van Der Gucht, Axel, et al.
Publicado: (2016)